HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Gómez-Hospital, J. A. Articles by Esplugas, E. Search for Related Content PubMed PubMed Citation Articles by Gómez-Hospital, J. A. Articles by Esplugas, E.

Partial Improvement in Pulmonary Function After Successful Percutaneous Balloon Mitral Valvotomy^*

^* From the Division of Cardiology (Drs. Gómez-Hospital, Cequier, Ugartemendia, Mauri, and Esplugas) and Division of Pulmonary Diseases (Drs. Romero and Cañete), Hospital de Bellvitge, University of Barcelona, Barcelona, Spain.

Correspondence to: Angel Cequier, MD, Cardiac Catheterization Laboratory, Hospital de Bellvitge, C. Feixa Llarga s/n, Hospitalet del Llobregat, 08907 Barcelona, Spain; e-mail: acequier{at}csub.scs.es

Study objectives: This study was performed to assess the changes in pulmonary function after a successful percutaneous balloon mitral valvotomy (PBMV) in 23 consecutive patients with symptomatic mitral stenosis.

Methods and results: Lung function preprocedure and postprocedure were evaluated by spirometric flow, static pulmonary volumes, and diffusion capacity of the lung for carbon monoxide (DLCO). At baseline, a reduction in small airways flow (maximal expiratory flow at 50% of vital capacity, 70 ± 29% of predicted value; maximal expiratory flow at 25% of vital capacity, 55 ± 26% of predicted value) and an increase in DLCO (118 ± 29%) and Krough Index (KCO; 123 ± 29% of predicted value) were observed. PBMV caused an improvement in hemodynamic parameters with an increase in mitral valve area (from 1.0 ± 0.3 to 1.9 ± 0.5 cm²; p < 0.001) and a decrease in left atrial pressure (from 17 ± 3 to 12 ± 5 mm Hg; p < 0.001). These changes were associated with a significant increase in FVC (from 2.8 ± 0.84 to 2.9 ± 0.80 L; p < 0.05) and in FEV₁ (from 2.2 ± 0.72 to 2.3 ± 0.68 L; p < 0.05). A decrease in DLCO was observed after PBMV (from 26.7 ± 7 to 22.5 ± 5.4 mL/min/mm Hg; p < 0.001; and KCO, from 6.2 ± 1.4 to 5.2 ± 1.2 mL/min/mm Hg/L; p < 0.001). No significant changes in small airways flow were detected, suggesting only a partial improvement in pulmonary congestion.

Conclusion: We conclude that the initial impairment of lung function in patients with symptomatic mitral stenosis is only partially ameliorated by PBMV.

Key Words: mitral stenosis • percutaneous balloon mitral valvotomy • pulmonary function

This article has been cited by other articles:

				J. A. Gomez-Hospital, A. Cequier, P. V. Romero, C. Canete, C. Ugartemendia, E. Iraculis, and E. Esplugas Persistence of Lung Function Abnormalities Despite Sustained Success of Percutaneous Mitral Valvotomy: The Need for an Early Indication Chest, January 1, 2005; 127(1): 40 - 46. [Abstract] [Full Text] [PDF]